Bert O'Neil
Physician · Community Health Network
Credentials: · · · ·
History
- 2021–Present
- 2004–2006
Medical Oncology
- 2001–2004
Internal Medicine
1997–2001
Research
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
Nature · 2019 · 1,832 citations
Journal of Clinical Oncology · 2020 · 801 citations
JAMA · 2017 · 770 citations
- RG
25 papers
- SS
19 papers · 3 as a fellow
18 papers
17 papers
17 papers
- AM
12 papers · 2 as a fellow
12 papers · 1 as a fellow
12 papers
Grants
- 2006–2011
Radiation-Induced Signaling and Treatment Resistance
National Cancer Institute · K23
Contact PI · $683.5K · Univ of North Carolina Chapel Hill
- 2003–2008
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $21.7K · Univ of North Carolina Chapel Hill
Clinical trials
- 2017–2019
Principal investigator · Terminated · Phase 2
Patrick Joseph Loehrer Sr.
- 2014–2016
Principal investigator · Withdrawn
Patrick Joseph Loehrer Sr.
- 2008–2010
Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis
Principal investigator · Terminated · Phase 1
UNC Lineberger Comprehensive Cancer Center
- 2007–2012
Selumetinib in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)